Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 03, 2026
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
10:15pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
In the latest trading session, Exact Sciences (EXAS) closed at $71.32, marking a -0.78% move from the previous day.
ARKK: The Bubble Has Already Been Burst - Don't Miss The Bottom
05:59pm, Wednesday, 30'th Mar 2022 Seeking Alpha
Bearish investors have gotten overly pessimistic over ARKK and tech stocks. As such, these investors missed the recent bottom. See why ARKK is a buy.
Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar?
10:20am, Tuesday, 22'nd Mar 2022 Zacks Investment Research
Style Box ETF report for GSEW
Exact Sciences (EXAS) Stock Sinks As Market Gains: What You Should Know
10:15pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
In the latest trading session, Exact Sciences (EXAS) closed at $57.56, marking a -1.96% move from the previous day.
Exact Sciences (EXAS) Cologuard Sales Up but Costs Rise
03:34pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Following the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is offering therapy selection tests for patients with advanced cancer.
Exact Sciences (EXAS) Cologuard Sales Up but Costs Rise
12:48pm, Tuesday, 15'th Mar 2022
Following the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is offering therapy selection tests for patients with advanced cancer.
Tesla, Coinbase, Exact Sciences And More: How Cathie Wood's Top 10 Bets Are Faring In 2022 So Far
11:46am, Monday, 14'th Mar 2022 Benzinga
Popular stockpicker Cathie Wood-led Ark Investment Management’s top ten key bets — spread across clean energy, innovation, tech, healthcare, and space sectors that constitute nearly half of its
Tesla, Coinbase, Exact Sciences And More: How Cathie Wood''s Top 10 Bets Are Faring In 2022 So Far
11:46am, Monday, 14'th Mar 2022 Benzinga
Popular stockpicker Cathie Wood-led Ark Investment Management ’s top ten key bets — spread across clean energy, innovation, tech, healthcare, and space sectors that constitute nearly half of its investments are not faring well in 2022 — as the first quarter nears an end. Each of the high-flying stocks that are spread across six of Ark Invest’s exchange-traded funds is down in the range of 23% to 55% so far this year. Despite the dip, the St. Petersburg, Florida-based Ark Invest has stayed the course and has been piling up shares in companies that make up the top ten constituents of its portfolio on every single dip, a closer analysis of the data showed. Here’s a look at where the top ten investments are at now in 2022. Tesla Inc (NASDAQ: TSLA ) : Wood, famous for making bets on high-growth disruptive firms, continues to count Tesla as its top investment. The Elon Musk -led company’s stock is down 33.7% so far this year at around $800 levels now after trading at $1,200 levels at the beginning of the year.
Tesla, Coinbase, Exact Sciences And More: How Cathie Wood's Top 10 Bets Are Faring In 2022 So Far
07:57am, Monday, 14'th Mar 2022
Popular stockpicker Cathie Wood-led Ark Investment Management's top ten key bets — spread across clean energy, innovation, tech, healthcare, and space sectors that constitute nearly half of its i
Exact Sciences (EXAS) Gains But Lags Market: What You Should Know
11:15pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
Exact Sciences (EXAS) closed at $72.26 in the latest trading session, marking a +0.81% move from the prior day.
Exact Sciences (EXAS) Gains But Lags Market: What You Should Know
07:33pm, Wednesday, 09'th Mar 2022
Exact Sciences (EXAS) closed at $72.26 in the latest trading session, marking a +0.81% move from the prior day.
This new competitor to the ARK Innovation ETF focuses on disruptive companies but aims to reduce volatility
06:21pm, Thursday, 03'rd Mar 2022 MarketWatch
The Harbor Disruptive Innovation ETF takes a broad approach to stock selection.
Exact Sciences to participate in March investor conferences
06:00am, Monday, 28'th Feb 2022
MADISON, Wis., Feb. 28, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that company management will participate in the following co
Invest in Next-Gen Technologies With These 2 ETFs
03:45pm, Thursday, 24'th Feb 2022 The Motley Fool
These funds focus on revolutions in healthcare and technology.
Thursday''s top analyst upgrades and downgrades included Caesars Entertainment, Chevron, Exact Sciences, Exxon Mobil, Gap, Ginkgo Bioworks, Home Depot, New York Mortgage Trust, Novavax, NOV and SoFi Technologies.
